Positron-emission tomography (PET) is an important oncologic imaging tool for primary tumor staging, evaluation of treatment response, recurrence detection, and restaging. Combined with computed tomography (CT), PET/CT has increased the diagnostic accuracy and dramatically reduced the acquisition time. This article describes the normal uptake, distribution, and excretion of Fluorine-18-labeled deoxyglucose (l8F FDG) as well as normal variations, response to treatment regimes, artifacts, and potential pitfalls that are important for correct image interpretation of whole-body PET/CT in oncology.
|Original language||English (US)|
|Number of pages||15|
|State||Published - Jun 1 2006|
ASJC Scopus subject areas
- Radiology Nuclear Medicine and imaging